PRKAA1 and colitis: In the present study, we found that during the initiation and development of colitis, AMPK phosphorylation on Thr172, as the activate form of AMPK, was gradually decreased while the expression of total AMPK was unchanged, and reactivation of AMPK by metformin could significantly reduce the severity of DSS-induced colitis.